rebound

Paxlovid rebound patient showed no drug resistance or impaired immunity - Pharmacology and Drug News

Paxlovid rebound patient showed no drug resistance or impaired immunity – Pharmacology and Drug News

Paxlovid is the main oral medicine to prevent severe cases of COVID-19 in people at high risk. However, symptoms returned in some patients after treatment ended, prompting the Centers for Disease Control and Prevention (CDC) to issue a health advisory about this so-called “COVID-19 rebound.” In a study published June 20, 2022 in Clinical infectious …

Paxlovid rebound patient showed no drug resistance or impaired immunity – Pharmacology and Drug News Read More »

Stock market: Wall Street offers a rebound, driven by technology

Stock market: Wall Street offers a rebound, driven by technology

(Photo: Getty Images) MARKET REVIEWS. The New York Stock Exchange rallied on Tuesday, buoyed by technology stocks and bargain-hunting investors after seven weeks of losses for the Nasdaq. To (re)consult market news Stock indices at closing In Toronto, the S&P/TSX it rose 284.60 points (+1.41%) to 20,491.01 points. In New York, the S&P500 it advanced …

Stock market: Wall Street offers a rebound, driven by technology Read More »